General Information

MaintermMORPHOLINE
Doc TypeNIL
CAS Reg.No.(or other ID)110-91-8
Regnum 175.105
176.180
176.210
178.3300
173.310

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID8083
IUPAC Namemorpholine
InChIInChI=1S/C4H9NO/c1-3-6-4-2-5-1/h5H,1-4H2
InChI KeyYNAVUWVOSKDBBP-UHFFFAOYSA-N
Canonical SMILESC1COCCN1
Molecular FormulaC4H9NO
Wikipediamorpholine

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight87.122
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Complexity34.5
CACTVS Substructure Key Fingerprint A A A D c c B i I A A A A A A A A A A A A A A A A A A A A A A A A A A s A A A A A A A A A A A A A A A A H g A Q A A A A A A D h g A Y A A A L A B A A A A A A A A A A A A A A A A A A A A I A I A A A C A A A A A A A D A A A A E A C Q A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area21.3
Monoisotopic Mass87.068
Exact Mass87.068
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count6
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


Food Additives Biosynthesis/Degradation


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9753
Human Intestinal AbsorptionHIA+0.9850
Caco-2 PermeabilityCaco2+0.6342
P-glycoprotein SubstrateNon-substrate0.5086
P-glycoprotein InhibitorNon-inhibitor0.9693
Non-inhibitor0.9936
Renal Organic Cation TransporterNon-inhibitor0.5935
Distribution
Subcellular localizationLysosome0.8622
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8983
CYP450 2D6 SubstrateNon-substrate0.7311
CYP450 3A4 SubstrateNon-substrate0.7882
CYP450 1A2 InhibitorNon-inhibitor0.8450
CYP450 2C9 InhibitorNon-inhibitor0.9512
CYP450 2D6 InhibitorNon-inhibitor0.8719
CYP450 2C19 InhibitorNon-inhibitor0.9202
CYP450 3A4 InhibitorNon-inhibitor0.9833
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.9724
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionStrong inhibitor0.6759
Non-inhibitor0.9262
AMES ToxicityNon AMES toxic0.9132
CarcinogensNon-carcinogens0.9292
Fish ToxicityLow FHMT0.9712
Tetrahymena Pyriformis ToxicityLow TPT0.9014
Honey Bee ToxicityLow HBT0.6362
BiodegradationNot ready biodegradable0.7803
Acute Oral ToxicityIII0.7819
Carcinogenicity (Three-class)Non-required0.6363

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility0.9976LogS
Caco-2 Permeability1.5590LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity1.8105LD50, mol/kg
Fish Toxicity3.3914pLC50, mg/L
Tetrahymena Pyriformis Toxicity-0.6598pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassOxazinanes
SubclassMorpholines
Intermediate Tree NodesNot available
Direct ParentMorpholines
Alternative Parents
Molecular FrameworkAliphatic heteromonocyclic compounds
SubstituentsMorpholine - Oxacycle - Azacycle - Secondary amine - Ether - Secondary aliphatic amine - Dialkyl ether - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Amine - Aliphatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as morpholines. These are organic compounds containing a morpholine moiety, which consists of a six-member aliphatic saturated ring with the formula C4H9NO, where the oxygen and nitrogen atoms lie at positions 1 and 4, respectively.

From ClassyFire